{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T00:06:44Z","timestamp":1793923604020,"version":"4.8.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T00:00:00Z","timestamp":1729123200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","award":["407940_206504"],"award-info":[{"award-number":["407940_206504"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100030692","name":"Intramural Research Program, National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100030692","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000733","name":"Universities Federation for Animal Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000733","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018780","name":"Animal Welfare Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.ebiom.2024.105434","type":"journal-article","created":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T04:31:09Z","timestamp":1730953869000},"page":"105434","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Which experimental factors govern successful animal-to-human translation in multiple sclerosis drug development? A\u00a0systematic review and meta-analysis"],"prefix":"10.1016","volume":"110","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7058-1969","authenticated-orcid":false,"given":"Ingrid","family":"Berg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pia","family":"H\u00e4rvelid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang Emanuel","family":"Z\u00fcrrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna","family":"Rosso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel S.","family":"Reich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1362-4819","authenticated-orcid":false,"given":"Benjamin Victor","family":"Ineichen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ebiom.2024.105434_bib1","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/ana.20913","article-title":"How to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosis","volume":"60","author":"Steinman","year":"2006","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ebiom.2024.105434_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2020.102371","article-title":"Magnetic resonance imaging in multiple sclerosis animal models: a systematic review, meta-analysis, and white paper","volume":"28","author":"Ineichen","year":"2020","journal-title":"Neuroimage Clin"},{"issue":"8","key":"10.1016\/j.ebiom.2024.105434_bib3","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S1474-4422(11)70149-1","article-title":"Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoring","volume":"10","author":"Kappos","year":"2011","journal-title":"Lancet Neurol"},{"issue":"Pt 8","key":"10.1016\/j.ebiom.2024.105434_bib4","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1093\/brain\/awl083","article-title":"The value of animal models for drug development in multiple sclerosis","volume":"129","author":"Friese","year":"2006","journal-title":"Brain"},{"issue":"Pt 8","key":"10.1016\/j.ebiom.2024.105434_bib5","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1093\/brain\/awl075","article-title":"Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research","volume":"129","author":"Gold","year":"2006","journal-title":"Brain"},{"issue":"10","key":"10.1016\/j.ebiom.2024.105434_bib6","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1038\/nm1664","article-title":"LINGO-1 antagonist promotes spinal cord remyelination and axonal integrity in MOG-induced experimental autoimmune encephalomyelitis","volume":"13","author":"Mi","year":"2007","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.ebiom.2024.105434_bib7","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/ana.21581","article-title":"Promotion of central nervous system remyelination by induced differentiation of oligodendrocyte precursor cells","volume":"65","author":"Mi","year":"2009","journal-title":"Ann Neurol"},{"issue":"14","key":"10.1016\/j.ebiom.2024.105434_bib8","doi-asserted-by":"crossref","DOI":"10.21037\/atm.2020.03.131","article-title":"Opicinumab: is it a potential treatment for multiple sclerosis?","volume":"8","author":"Ahmed","year":"2020","journal-title":"Ann Transl Med"},{"issue":"6","key":"10.1016\/j.ebiom.2024.105434_bib9","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/joim.13215","article-title":"Current and emerging disease-modulatory therapies and treatment targets for multiple sclerosis","volume":"289","author":"Piehl","year":"2021","journal-title":"J\u00a0Intern Med"},{"issue":"12","key":"10.1016\/j.ebiom.2024.105434_bib10","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-029475","article-title":"Mapping the preclinical to clinical evidence and development trajectory of the oncolytic virus talimogene laherparepvec (T-VEC): a systematic review","volume":"9","author":"Lalu","year":"2019","journal-title":"BMJ Open"},{"issue":"9912","key":"10.1016\/j.ebiom.2024.105434_bib11","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0140-6736(13)62329-6","article-title":"Biomedical research: increasing value, reducing waste","volume":"383","author":"Macleod","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.ebiom.2024.105434_bib12","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2165\/11537160-000000000-00000","article-title":"Therapeutic approaches to multiple sclerosis: an update on failed, interrupted, or inconclusive trials of immunomodulatory treatment strategies","volume":"24","author":"Ulzheimer","year":"2010","journal-title":"BioDrugs"},{"issue":"6","key":"10.1016\/j.ebiom.2024.105434_bib13","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1080\/14737175.2016.1176531","article-title":"Failed, interrupted and inconclusive trials on relapsing multiple sclerosis treatment: update 2010\u20132015","volume":"16","author":"Pfeuffer","year":"2016","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.ebiom.2024.105434_bib14","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s40259-020-00435-w","article-title":"Failed, interrupted, or inconclusive trials on immunomodulatory treatment strategies in multiple sclerosis: update 2015\u20132020","volume":"34","author":"Rolfes","year":"2020","journal-title":"BioDrugs"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105434_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13643-021-01626-4","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"10","author":"Page","year":"2021","journal-title":"Syst Rev"},{"key":"10.1016\/j.ebiom.2024.105434_bib16","article-title":"Rituximab treatment for multiple sclerosis","author":"Ineichen","year":"2019","journal-title":"Mult Scler"},{"issue":"2","key":"10.1016\/j.ebiom.2024.105434_bib17","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/s42256-020-00287-7","article-title":"An open source machine learning framework for efficient and transparent systematic reviews","volume":"3","author":"van de Schoot","year":"2021","journal-title":"Nat Mach Intell"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105434_bib18","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s13643-024-02502-7","article-title":"The SAFE procedure: a practical stopping heuristic for active learning-based screening in systematic reviews and meta-analyses","volume":"13","author":"Boetje","year":"2024","journal-title":"Syst Rev"},{"issue":"9","key":"10.1016\/j.ebiom.2024.105434_bib19","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1177\/13524585231189671","article-title":"Improving the efficiency of clinical trials in multiple sclerosis","volume":"29","author":"Marrie","year":"2023","journal-title":"Mult Scler J"},{"issue":"2","key":"10.1016\/j.ebiom.2024.105434_bib20","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/jcbfm.2008.101","article-title":"Reprint: good laboratory practice: preventing introduction of bias at the bench","volume":"29","author":"Macleod","year":"2009","journal-title":"J\u00a0Cerebr Blood Flow Metabol"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105434_bib21","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/s41598-018-35734-4","article-title":"Remyelination promoting therapies in multiple sclerosis animal models: a systematic review and meta-analysis","volume":"9","author":"Hooijmans","year":"2019","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105434_bib22","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12874-024-02146-0","article-title":"Navigating PROSPERO4animals: 10 top tips for efficient pre-registration of your animal systematic review protocol","volume":"24","author":"Bannach-Brown","year":"2024","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.ebiom.2024.105434_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2023.1135282","article-title":"Neuroimaging findings in preclinical amyotrophic lateral sclerosis models-How well do they mimic the clinical phenotype? A systematic review","volume":"10","author":"Cannon","year":"2023","journal-title":"Front Vet Sci"},{"key":"10.1016\/j.ebiom.2024.105434_bib24","article-title":"Auto-STEED: a data mining tool for automated extraction of experimental parameters and risk of bias items from in\u00a0vivo publications","author":"Zurrer","year":"2023","journal-title":"bioRxiv"},{"key":"10.1016\/j.ebiom.2024.105434_bib25","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1471-2288-14-43","article-title":"SYRCLE's risk of bias tool for animal studies","volume":"14","author":"Hooijmans","year":"2014","journal-title":"BMC Med Res Methodol"},{"issue":"3","key":"10.1016\/j.ebiom.2024.105434_bib26","first-page":"1","article-title":"Conducting meta-analyses in R with the metafor package","volume":"36","author":"Viechtbauer","year":"2010","journal-title":"J\u00a0Stat Software"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105434_bib27","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1467-985X.2008.00552.x","article-title":"A\u00a0re-evaluation of random-effects meta-analysis","volume":"172","author":"Higgins","year":"2009","journal-title":"J\u00a0Roy Stat Soc Stat Soc"},{"issue":"6","key":"10.1016\/j.ebiom.2024.105434_bib28","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1161\/STROKEAHA.108.541128","article-title":"Update of the stroke therapy academic industry roundtable preclinical recommendations","volume":"40","author":"Fisher","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.ebiom.2024.105434_bib29","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.24260","article-title":"Standardized mean differences cause funnel plot distortion in publication bias assessments","volume":"6","author":"Zwetsloot","year":"2017","journal-title":"Elife"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105434_bib30","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J\u00a0Roy Stat Soc B"},{"issue":"2","key":"10.1016\/j.ebiom.2024.105434_bib31","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1177\/1352458519858604","article-title":"Rituximab treatment for multiple sclerosis","volume":"26","author":"Ineichen","year":"2020","journal-title":"Mult Scler"},{"key":"10.1016\/j.ebiom.2024.105434_bib32","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00401-016-1631-4","article-title":"Multiple sclerosis: experimental models and reality","volume":"133","author":"Lassmann","year":"2016","journal-title":"Acta Neuropathol"},{"issue":"3","key":"10.1016\/j.ebiom.2024.105434_bib33","doi-asserted-by":"crossref","first-page":"a028936","DOI":"10.1101\/cshperspect.a028936","article-title":"Multiple sclerosis pathology","volume":"8","author":"Lassmann","year":"2018","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.ebiom.2024.105434_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2023.106230","article-title":"An overall view of the most common experimental models for multiple sclerosis","volume":"184","author":"Dedoni","year":"2023","journal-title":"Neurobiol Dis"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105434_bib35","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s42826-022-00128-1","article-title":"Role of animal models in biomedical research: a review","volume":"38","author":"Mukherjee","year":"2022","journal-title":"Lab Anim Res"},{"issue":"7","key":"10.1016\/j.ebiom.2024.105434_bib36","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/nrg.2017.19","article-title":"Comparative transcriptomics in human and mouse","volume":"18","author":"Breschi","year":"2017","journal-title":"Nat Rev Genet"},{"issue":"10","key":"10.1016\/j.ebiom.2024.105434_bib37","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1172\/JCI9213","article-title":"Estrogen potentiates treatment with T-cell receptor protein of female mice with experimental encephalomyelitis","volume":"105","author":"Offner","year":"2000","journal-title":"J\u00a0Clin Invest"},{"issue":"3","key":"10.1016\/j.ebiom.2024.105434_bib38","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.neubiorev.2010.07.002","article-title":"Sex bias in neuroscience and biomedical research","volume":"35","author":"Beery","year":"2011","journal-title":"Neurosci Biobehav Rev"},{"issue":"5","key":"10.1016\/j.ebiom.2024.105434_bib39","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1177\/1352458519892491","article-title":"The effect of sex on multiple sclerosis risk and disease progression","volume":"26","author":"Voskuhl","year":"2020","journal-title":"Mult Scler J"},{"key":"10.1016\/j.ebiom.2024.105434_bib40","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.shpsa.2021.06.016","article-title":"Scientific inertia in animal-based research in biomedicine","volume":"89","author":"Lohse","year":"2021","journal-title":"Stud Hist Philos Sci"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105434_bib41","first-page":"49","article-title":"Tradition, not science, is the basis of animal model selection in translational and applied research","volume":"38","author":"Veening-Griffioen","year":"2021","journal-title":"ALTEX"},{"key":"10.1016\/j.ebiom.2024.105434_bib42","series-title":"The mouse in biomedical research","first-page":"637","author":"Flurkey","year":"2007"},{"issue":"9","key":"10.1016\/j.ebiom.2024.105434_bib43","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1161\/STROKEAHA.117.017112","article-title":"Translational stroke research: vision and opportunities","volume":"48","author":"Bosetti","year":"2017","journal-title":"Stroke"},{"key":"10.1016\/j.ebiom.2024.105434_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.107811","article-title":"The current approach of the Epilepsy Therapy Screening Program contract site for identifying improved therapies for the treatment of pharmacoresistant seizures in epilepsy","volume":"166","author":"Wilcox","year":"2020","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.ebiom.2024.105434_bib45","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1161\/CIRCRESAHA.116.305462","article-title":"The NHLBI-sponsored consortium for preclinicAl assESsment of cARdioprotective therapies (CAESAR) A new paradigm for rigorous, accurate, and reproducible evaluation of putative infarct-sparing interventions in mice, rabbits, and pigs","volume":"116","author":"Jones","year":"2015","journal-title":"Circ Res"},{"issue":"6","key":"10.1016\/j.ebiom.2024.105434_bib46","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1089\/neu.2015.4113","article-title":"Approach to modeling, therapy evaluation, drug selection, and biomarker assessments for a multicenter pre-clinical drug screening consortium for acute therapies in severe traumatic brain injury: operation brain trauma therapy","volume":"33","author":"Kochanek","year":"2016","journal-title":"J\u00a0Neurotrauma"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105434_bib47","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41592-020-01036-9","article-title":"The standardization fallacy","volume":"18","author":"Voelkl","year":"2021","journal-title":"Nat Methods"},{"issue":"12","key":"10.1016\/j.ebiom.2024.105434_bib48","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1038\/s41591-019-0670-5","article-title":"Academic leadership: (with)holding the keys to translational medicine?","volume":"25","author":"Ogier","year":"2019","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.ebiom.2024.105434_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0170444","article-title":"Encouraging entrepreneurship in university labs: research activities, research outputs, and early doctorate careers","volume":"12","author":"Roach","year":"2017","journal-title":"PLoS One"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396424004705?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396424004705?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T16:58:04Z","timestamp":1733936284000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396424004705"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":49,"alternative-id":["S2352396424004705"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2024.105434","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Which experimental factors govern successful animal-to-human translation in multiple sclerosis drug development? A\u00a0systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2024.105434","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105434"}}